Factors influencing the time to thrombolysis in acute myocardial infarction

Costas T. Lambrew, Laura J. Bowlby, William J. Rogers, Nisha Chandra, W. Douglas Weaver

Research output: Contribution to journalArticle

Abstract

Background: The Time to Thrombolysis Substudy of the National Registry for Myocardial Infarction provided the opportunity to identify factors that delay thrombolytic treatment of patients with ST-segment elevation acute myocardial infarction. Participants: Forty-two participating registry hospitals volunteered for the Time to Thrombolysis Substudy. Methods: A case report form was developed to collect time points for emergency department arrival (door), recording of the electrocardiogram (ECG) (data), entry of the order to give a thrombolytic drug (decision), and initiation of the thrombolytic infusion (drug) as defined by the National Heart Attack Alert Program. The impact of mode of transportation to the hospital, sex, policy- driven cardiology consultation and/or contact of the primary care physician on door-to-drug time, and each component interval were determined in 1755 patients who were treated with recombinant tissue-type plasminogen activator (Alteplase). The t test was used for comparison of means and the nonparametric sign test was used for medians. Results: A minority of patients arrived at the hospital by ambulance, although more women (49.6%) arrived by ambulance than men (40.9%). However, women arrived at hospitals significantly later after onset of symptoms than men. It took half as long for patients arriving by ambulance to be seen by the physician than those who transported themselves to the hospital. It took longer for women to have the initial 12- lead ECG recorded than men. The decision to order a thrombolytic agent was delayed by 22 minutes and median door-to-drug time by 21 minutes in those patients who had a cardiac consultation over those in whom the drug was ordered and infusion was initiated by the emergency physician. Although the initial 12-lead ECG showed ST-segment elevation in 86% of patients who received the thrombolytic drugs, with no difference between men and women and no difference in the rate of cardiology consultation between men and women (77%), door-to-decision time and door-to-drug time were substantially longer for women having consultation than men. There was no significant difference in door-to-decision time between men and women when no consultation was performed, but it still took longer for a drug infusion to be initiated in women. Contacting the primary care physician delayed the decision to give a thrombolytic drug by 18 minutes and the administration of the drug by 20 minutes, but there were no differences between men and women. Preparation of the drug in the pharmacy resulted in significant delay compared with mixing it in the emergency department. Conclusions: Hospital practices and policies, including contacting the primary care physician prior to the initiation of a lytic drug, cardiology consultation, and preparation of the drug in the pharmacy rather than in the emergency department, significantly delay the goal of early treatment of patients with ST segment elevation acute myocardial infarction. Delays in hospital arrival for women are compounded by delays in the decision to treat them with a thrombolytic drug and initiation of the drug therapy in those women who receive consultation compared with men. Other delays in acquiring the first ECG and initiating the drug infusion in women are not explained.

Original languageEnglish (US)
Pages (from-to)2577-2582
Number of pages6
JournalArchives of Internal Medicine
Volume157
Issue number22
StatePublished - 1997

Fingerprint

Myocardial Infarction
Fibrinolytic Agents
Referral and Consultation
Pharmaceutical Preparations
Ambulances
Electrocardiography
Primary Care Physicians
Cardiology
Hospital Emergency Service
Drug Compounding
Tissue Plasminogen Activator
Registries
Physicians
Emergencies
Drug Therapy
Therapeutics

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Lambrew, C. T., Bowlby, L. J., Rogers, W. J., Chandra, N., & Douglas Weaver, W. (1997). Factors influencing the time to thrombolysis in acute myocardial infarction. Archives of Internal Medicine, 157(22), 2577-2582.

Factors influencing the time to thrombolysis in acute myocardial infarction. / Lambrew, Costas T.; Bowlby, Laura J.; Rogers, William J.; Chandra, Nisha; Douglas Weaver, W.

In: Archives of Internal Medicine, Vol. 157, No. 22, 1997, p. 2577-2582.

Research output: Contribution to journalArticle

Lambrew, CT, Bowlby, LJ, Rogers, WJ, Chandra, N & Douglas Weaver, W 1997, 'Factors influencing the time to thrombolysis in acute myocardial infarction', Archives of Internal Medicine, vol. 157, no. 22, pp. 2577-2582.
Lambrew CT, Bowlby LJ, Rogers WJ, Chandra N, Douglas Weaver W. Factors influencing the time to thrombolysis in acute myocardial infarction. Archives of Internal Medicine. 1997;157(22):2577-2582.
Lambrew, Costas T. ; Bowlby, Laura J. ; Rogers, William J. ; Chandra, Nisha ; Douglas Weaver, W. / Factors influencing the time to thrombolysis in acute myocardial infarction. In: Archives of Internal Medicine. 1997 ; Vol. 157, No. 22. pp. 2577-2582.
@article{aeded8ee20e742b0a6ebfa4e6fff9e21,
title = "Factors influencing the time to thrombolysis in acute myocardial infarction",
abstract = "Background: The Time to Thrombolysis Substudy of the National Registry for Myocardial Infarction provided the opportunity to identify factors that delay thrombolytic treatment of patients with ST-segment elevation acute myocardial infarction. Participants: Forty-two participating registry hospitals volunteered for the Time to Thrombolysis Substudy. Methods: A case report form was developed to collect time points for emergency department arrival (door), recording of the electrocardiogram (ECG) (data), entry of the order to give a thrombolytic drug (decision), and initiation of the thrombolytic infusion (drug) as defined by the National Heart Attack Alert Program. The impact of mode of transportation to the hospital, sex, policy- driven cardiology consultation and/or contact of the primary care physician on door-to-drug time, and each component interval were determined in 1755 patients who were treated with recombinant tissue-type plasminogen activator (Alteplase). The t test was used for comparison of means and the nonparametric sign test was used for medians. Results: A minority of patients arrived at the hospital by ambulance, although more women (49.6{\%}) arrived by ambulance than men (40.9{\%}). However, women arrived at hospitals significantly later after onset of symptoms than men. It took half as long for patients arriving by ambulance to be seen by the physician than those who transported themselves to the hospital. It took longer for women to have the initial 12- lead ECG recorded than men. The decision to order a thrombolytic agent was delayed by 22 minutes and median door-to-drug time by 21 minutes in those patients who had a cardiac consultation over those in whom the drug was ordered and infusion was initiated by the emergency physician. Although the initial 12-lead ECG showed ST-segment elevation in 86{\%} of patients who received the thrombolytic drugs, with no difference between men and women and no difference in the rate of cardiology consultation between men and women (77{\%}), door-to-decision time and door-to-drug time were substantially longer for women having consultation than men. There was no significant difference in door-to-decision time between men and women when no consultation was performed, but it still took longer for a drug infusion to be initiated in women. Contacting the primary care physician delayed the decision to give a thrombolytic drug by 18 minutes and the administration of the drug by 20 minutes, but there were no differences between men and women. Preparation of the drug in the pharmacy resulted in significant delay compared with mixing it in the emergency department. Conclusions: Hospital practices and policies, including contacting the primary care physician prior to the initiation of a lytic drug, cardiology consultation, and preparation of the drug in the pharmacy rather than in the emergency department, significantly delay the goal of early treatment of patients with ST segment elevation acute myocardial infarction. Delays in hospital arrival for women are compounded by delays in the decision to treat them with a thrombolytic drug and initiation of the drug therapy in those women who receive consultation compared with men. Other delays in acquiring the first ECG and initiating the drug infusion in women are not explained.",
author = "Lambrew, {Costas T.} and Bowlby, {Laura J.} and Rogers, {William J.} and Nisha Chandra and {Douglas Weaver}, W.",
year = "1997",
language = "English (US)",
volume = "157",
pages = "2577--2582",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
number = "22",

}

TY - JOUR

T1 - Factors influencing the time to thrombolysis in acute myocardial infarction

AU - Lambrew, Costas T.

AU - Bowlby, Laura J.

AU - Rogers, William J.

AU - Chandra, Nisha

AU - Douglas Weaver, W.

PY - 1997

Y1 - 1997

N2 - Background: The Time to Thrombolysis Substudy of the National Registry for Myocardial Infarction provided the opportunity to identify factors that delay thrombolytic treatment of patients with ST-segment elevation acute myocardial infarction. Participants: Forty-two participating registry hospitals volunteered for the Time to Thrombolysis Substudy. Methods: A case report form was developed to collect time points for emergency department arrival (door), recording of the electrocardiogram (ECG) (data), entry of the order to give a thrombolytic drug (decision), and initiation of the thrombolytic infusion (drug) as defined by the National Heart Attack Alert Program. The impact of mode of transportation to the hospital, sex, policy- driven cardiology consultation and/or contact of the primary care physician on door-to-drug time, and each component interval were determined in 1755 patients who were treated with recombinant tissue-type plasminogen activator (Alteplase). The t test was used for comparison of means and the nonparametric sign test was used for medians. Results: A minority of patients arrived at the hospital by ambulance, although more women (49.6%) arrived by ambulance than men (40.9%). However, women arrived at hospitals significantly later after onset of symptoms than men. It took half as long for patients arriving by ambulance to be seen by the physician than those who transported themselves to the hospital. It took longer for women to have the initial 12- lead ECG recorded than men. The decision to order a thrombolytic agent was delayed by 22 minutes and median door-to-drug time by 21 minutes in those patients who had a cardiac consultation over those in whom the drug was ordered and infusion was initiated by the emergency physician. Although the initial 12-lead ECG showed ST-segment elevation in 86% of patients who received the thrombolytic drugs, with no difference between men and women and no difference in the rate of cardiology consultation between men and women (77%), door-to-decision time and door-to-drug time were substantially longer for women having consultation than men. There was no significant difference in door-to-decision time between men and women when no consultation was performed, but it still took longer for a drug infusion to be initiated in women. Contacting the primary care physician delayed the decision to give a thrombolytic drug by 18 minutes and the administration of the drug by 20 minutes, but there were no differences between men and women. Preparation of the drug in the pharmacy resulted in significant delay compared with mixing it in the emergency department. Conclusions: Hospital practices and policies, including contacting the primary care physician prior to the initiation of a lytic drug, cardiology consultation, and preparation of the drug in the pharmacy rather than in the emergency department, significantly delay the goal of early treatment of patients with ST segment elevation acute myocardial infarction. Delays in hospital arrival for women are compounded by delays in the decision to treat them with a thrombolytic drug and initiation of the drug therapy in those women who receive consultation compared with men. Other delays in acquiring the first ECG and initiating the drug infusion in women are not explained.

AB - Background: The Time to Thrombolysis Substudy of the National Registry for Myocardial Infarction provided the opportunity to identify factors that delay thrombolytic treatment of patients with ST-segment elevation acute myocardial infarction. Participants: Forty-two participating registry hospitals volunteered for the Time to Thrombolysis Substudy. Methods: A case report form was developed to collect time points for emergency department arrival (door), recording of the electrocardiogram (ECG) (data), entry of the order to give a thrombolytic drug (decision), and initiation of the thrombolytic infusion (drug) as defined by the National Heart Attack Alert Program. The impact of mode of transportation to the hospital, sex, policy- driven cardiology consultation and/or contact of the primary care physician on door-to-drug time, and each component interval were determined in 1755 patients who were treated with recombinant tissue-type plasminogen activator (Alteplase). The t test was used for comparison of means and the nonparametric sign test was used for medians. Results: A minority of patients arrived at the hospital by ambulance, although more women (49.6%) arrived by ambulance than men (40.9%). However, women arrived at hospitals significantly later after onset of symptoms than men. It took half as long for patients arriving by ambulance to be seen by the physician than those who transported themselves to the hospital. It took longer for women to have the initial 12- lead ECG recorded than men. The decision to order a thrombolytic agent was delayed by 22 minutes and median door-to-drug time by 21 minutes in those patients who had a cardiac consultation over those in whom the drug was ordered and infusion was initiated by the emergency physician. Although the initial 12-lead ECG showed ST-segment elevation in 86% of patients who received the thrombolytic drugs, with no difference between men and women and no difference in the rate of cardiology consultation between men and women (77%), door-to-decision time and door-to-drug time were substantially longer for women having consultation than men. There was no significant difference in door-to-decision time between men and women when no consultation was performed, but it still took longer for a drug infusion to be initiated in women. Contacting the primary care physician delayed the decision to give a thrombolytic drug by 18 minutes and the administration of the drug by 20 minutes, but there were no differences between men and women. Preparation of the drug in the pharmacy resulted in significant delay compared with mixing it in the emergency department. Conclusions: Hospital practices and policies, including contacting the primary care physician prior to the initiation of a lytic drug, cardiology consultation, and preparation of the drug in the pharmacy rather than in the emergency department, significantly delay the goal of early treatment of patients with ST segment elevation acute myocardial infarction. Delays in hospital arrival for women are compounded by delays in the decision to treat them with a thrombolytic drug and initiation of the drug therapy in those women who receive consultation compared with men. Other delays in acquiring the first ECG and initiating the drug infusion in women are not explained.

UR - http://www.scopus.com/inward/record.url?scp=0030669883&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030669883&partnerID=8YFLogxK

M3 - Article

VL - 157

SP - 2577

EP - 2582

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 22

ER -